AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#100135, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

Grant

Date/time Interval

  • October 23, 2015 - October 22, 2020
  • Total Award Amount

  • 49000.00
  • Direct Costs

  • 38890.00
  • Sponsor Award Id

  • Contributor

  • Alva, Elizabeth   Investigator  
  • Aye, Jamie   Investigator  
  • Bemrich-Stolz, Christina   Investigator  
  • Bhatia M.D., Smita   Investigator  
  • Chewning III M.D., Joseph   Investigator  
  • Friedman M.D., Gregory   Investigator  
  • Galtarossa Xavier, Ana   Investigator  
  • Goldman M.D., Frederick   Investigator  
  • Haines, Hilary   Investigator  
  • Hilliard, Lee   Investigator  
  • Kutny M.D., Matthew   Principal Investigator  
  • Lebensburger, Jeffrey   Investigator  
  • Wadhwa, Aman   Investigator  
  • Whelan M.D., Kimberly   Investigator  
  • Wolfson-Stockman M.D., Julie   Investigator